Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04594993 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

INFINITY™ With ADAPTIS™ Technology Study

Study acronym: ITAR2
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv17
  2. Study sites revised (13)v16 See this version in full on ClinicalTrials.gov ↗
  3. Trial status: Recruiting to Active, Not Recruiting Site details revised at 13 of 13 sitesv15 Show 1 more changeShow less
    • Site details revised at 13 of 13 sites
  4. Trial status: Active, Not Recruiting to Recruiting Enrollment target: 206 to 200 · Study description revised · Site details revised at 13 of 13 sitesv14 Show 3 more changesShow less
    • Enrollment target: 206 to 200
    • Study description revised
    • Site details revised at 13 of 13 sites

    See this version in full on ClinicalTrials.gov ↗

  5. Re-verified, no change to tracked fieldsv13
Show 11 earlier versionsHide 11 earlier versions
  1. Trial status: Recruiting to Active, Not Recruiting Enrollment target: estimated 200 to confirmed 206 · Site details revised at 13 of 13 sitesv12 Show 2 more changesShow less
    • Enrollment target: estimated 200 to confirmed 206
    • Site details revised at 13 of 13 sites
  2. Study sites: 12 to 13v11
  3. Study sites: 10 to 12v10
  4. Study sites: 9 to 10v9
  5. Study sites: 8 to 9v8
  6. Study sites: 5 to 8v7
  7. Study description expanded, about 63 wordsv6 See this version in full on ClinicalTrials.gov ↗
  8. Site details revised at 1 of 5 sitesv5
  9. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 5 · Start date changed from estimate of Feb 28, 2021 to Feb 9, 2021v4 Show 2 more changesShow less
    • Study sites: 0 to 5
    • Start date changed from estimate of Feb 28, 2021 to Feb 9, 2021
  10. Start date: Nov 2020 to Feb 28, 2021v3
  11. Secondary endpoints: details revised at 1 of 5 entriesv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
INFINITY™ with ADAPTIS™ Technology Total Ankle Replacement Follow-up (ITAR2) - Prospective, multi-site, multi-year post-market clinical follow-up study Study Group Primary/Unilateral and/or bilateral Total Ankle Arthroplasty subjects implanted with INFINITY™ Total Ankle System Number of Subjects 200 patients with up to 13 sites
Trial Details
NCT Number NCT04594993
Lead Sponsor Stryker Trauma and Extremities
Conditions Arthritis, Rheumatoid
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov